These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
229 related articles for article (PubMed ID: 15320830)
1. Understanding the mechanism of platelet thrombus formation under blood flow conditions and the effect of new antiplatelet agents. Goto S Curr Vasc Pharmacol; 2004 Jan; 2(1):23-32. PubMed ID: 15320830 [TBL] [Abstract][Full Text] [Related]
2. Understanding the mechanism and prevention of arterial occlusive thrombus formation by anti-platelet agents. Goto S Curr Med Chem Cardiovasc Hematol Agents; 2004 Apr; 2(2):149-56. PubMed ID: 15320797 [TBL] [Abstract][Full Text] [Related]
3. Platelet thrombus formation on collagen at high shear rates is mediated by von Willebrand factor-glycoprotein Ib interaction and inhibited by von Willebrand factor-glycoprotein IIb/IIIa interaction. Wu YP; Vink T; Schiphorst M; van Zanten GH; IJsseldijk MJ; de Groot PG; Sixma JJ Arterioscler Thromb Vasc Biol; 2000 Jun; 20(6):1661-7. PubMed ID: 10845886 [TBL] [Abstract][Full Text] [Related]
4. Ability of different glycoprotein IIb-IIIa ligands to support platelet aggregation induced by activating antibody CRC54. Naimushin YA; Mazurov AV Biochemistry (Mosc); 2005 Jul; 70(7):782-9. PubMed ID: 16097942 [TBL] [Abstract][Full Text] [Related]
5. Antagonism of the GPIIb/IIIa receptor with the nonpeptidic molecule BIBU52: inhibition of platelet aggregation in vitro and antithrombotic efficacy in vivo. Guth BD; Seewaldt-Becker E; Himmelsbach F; Weisenberger H; Müller TH J Cardiovasc Pharmacol; 1997 Aug; 30(2):261-72. PubMed ID: 9269956 [TBL] [Abstract][Full Text] [Related]
6. Coronary thrombosis. Effects of blood flow on the mechanism of thrombus formation. Goto S; Handa S Jpn Heart J; 1998 Sep; 39(5):579-96. PubMed ID: 9925990 [TBL] [Abstract][Full Text] [Related]
7. Platelet adhesion receptors: novel targets for anti-thrombotic therapy. Williamson D; Giuliano S; Jackson SP Aust N Z J Med; 1999 Jun; 29(3):452-61. PubMed ID: 10868519 [TBL] [Abstract][Full Text] [Related]
8. [High shear stress induced platelet aggregation (h-SIPA) and effects of antiplatelet therapy]. Isaka N; Tanigawa T; Nishikawa M; Nakano T Nihon Rinsho; 1998 Oct; 56(10):2624-9. PubMed ID: 9796329 [TBL] [Abstract][Full Text] [Related]
9. An Updated Review on Glycoprotein IIb/IIIa Inhibitors as Antiplatelet Agents: Basic and Clinical Perspectives. Sharifi-Rad J; Sharopov F; Ezzat SM; Zam W; Ademiluyi AO; Oyeniran OH; Adetunji CO; Roli OI; Živković J; Martorell M; Docea AO; El Omari N; Bouyahya A; Lorenzo JM; Calina D High Blood Press Cardiovasc Prev; 2023 Mar; 30(2):93-107. PubMed ID: 36637623 [TBL] [Abstract][Full Text] [Related]
10. A revised model of platelet aggregation. Kulkarni S; Dopheide SM; Yap CL; Ravanat C; Freund M; Mangin P; Heel KA; Street A; Harper IS; Lanza F; Jackson SP J Clin Invest; 2000 Mar; 105(6):783-91. PubMed ID: 10727447 [TBL] [Abstract][Full Text] [Related]
11. Specific inhibiting characteristics of tetramethylpyrazine, one of the active ingredients of the Chinese herbal medicine 'Chuanxiong,' on platelet thrombus formation under high shear rates. Li M; Handa S; Ikeda Y; Goto S Thromb Res; 2001 Oct; 104(1):15-28. PubMed ID: 11583735 [TBL] [Abstract][Full Text] [Related]
12. Type IIB von Willebrand factor with normal sialic acid content induces platelet aggregation in the absence of ristocetin. Role of platelet activation, fibrinogen, and two distinct membrane receptors. De Marco L; Mazzuccato M; Grazia Del Ben M; Budde U; Federici AB; Girolami A; Ruggeri ZM J Clin Invest; 1987 Aug; 80(2):475-82. PubMed ID: 3038958 [TBL] [Abstract][Full Text] [Related]
13. [Anti-integrins--new platelet function inhibitors for therapy and prevention of acute coronary syndrome]. Schrör K Wien Klin Wochenschr; 1999 Feb; 111(3):90-7. PubMed ID: 10093890 [TBL] [Abstract][Full Text] [Related]
14. Interaction of asialo von Willebrand factor with glycoprotein Ib induces fibrinogen binding to the glycoprotein IIb/IIIa complex and mediates platelet aggregation. De Marco L; Girolami A; Russell S; Ruggeri ZM J Clin Invest; 1985 Apr; 75(4):1198-203. PubMed ID: 3157702 [TBL] [Abstract][Full Text] [Related]
15. Uremic patients have decreased shear-induced platelet aggregation mediated by decreased availability of glycoprotein IIb-IIIa receptors. Sreedhara R; Itagaki I; Hakim RM Am J Kidney Dis; 1996 Mar; 27(3):355-64. PubMed ID: 8604704 [TBL] [Abstract][Full Text] [Related]
16. High shear stress attenuates agonist-induced, glycoprotein IIb/IIIa-mediated platelet aggregation when von Willebrand factor binding to glycoprotein Ib/IX is blocked. Iijima K; Murata M; Nakamura K; Kitaguchi T; Handa M; Watanabe K; Fujimura Y; Yoshioka A; Ikeda Y Biochem Biophys Res Commun; 1997 Apr; 233(3):796-800. PubMed ID: 9168936 [TBL] [Abstract][Full Text] [Related]
17. The role of the platelet in the pathogenesis of atherothrombosis. Steinhubl SR; Moliterno DJ Am J Cardiovasc Drugs; 2005; 5(6):399-408. PubMed ID: 16259528 [TBL] [Abstract][Full Text] [Related]
18. Platelet receptors as therapeutic targets: Past, present and future. Jamasbi J; Ayabe K; Goto S; Nieswandt B; Peter K; Siess W Thromb Haemost; 2017 Jun; 117(7):1249-1257. PubMed ID: 28597906 [TBL] [Abstract][Full Text] [Related]
19. Antiplatelet and antithrombotic efficacy of DMP 728, a novel platelet GPIIb/IIIa receptor antagonist. Mousa SA; Bozarth JM; Forsythe MS; Jackson SM; Leamy A; Diemer MM; Kapil RP; Knabb RM; Mayo MC; Pierce SK Circulation; 1994 Jan; 89(1):3-12. PubMed ID: 8281661 [TBL] [Abstract][Full Text] [Related]
20. Real-time analysis of mural thrombus formation in various platelet aggregation disorders: distinct shear-dependent roles of platelet receptors and adhesive proteins under flow. Tsuji S; Sugimoto M; Miyata S; Kuwahara M; Kinoshita S; Yoshioka A Blood; 1999 Aug; 94(3):968-75. PubMed ID: 10419888 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]